| Year |
Citation |
Score |
| 2000 |
Maltais S, C té S, Drolet G, Falardeau P. Cellular colocalization of dopamine D1 mRNA and D2 receptor in rat brain using a D2 dopamine receptor specific polyclonal antibody. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 24: 1127-49. PMID 11131177 DOI: 10.1016/S0278-5846(00)00125-1 |
0.637 |
|
| 2000 |
Goulet M, Grondin R, Morissette M, Maltais S, Falardeau P, Bédard PJ, Di Paolo T. Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-monkeys. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 24: 607-17. PMID 10958154 DOI: 10.1016/S0278-5846(00)00096-8 |
0.65 |
|
| 1999 |
Masson J, Cervera P, Côté S, Morisette J, Aïdouni Z, Giros B, Hamon M, Falardeau P, Mestikawy SE. Characterization and distribution of Hxt1, a Na(+)/Cl(-)-dependent orphan transporter, in the human brain. Journal of Neuroscience Research. 56: 146-59. PMID 10494103 DOI: 10.1002/(Sici)1097-4547(19990415)56:2<146::Aid-Jnr4>3.0.Co;2-# |
0.3 |
|
| 1999 |
Goulet M, Morissette M, Grondin R, Falardeau P, Bédard PJ, Rostène W, Di Paolo T. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys. Synapse (New York, N.Y.). 32: 153-64. PMID 10340626 DOI: 10.1002/(Sici)1098-2396(19990601)32:3<153::Aid-Syn2>3.0.Co;2-X |
0.589 |
|
| 1997 |
Goulet M, Morissette M, Calon F, Blanchet PJ, Falardeau P, Bédard PJ, Di Paolo T. Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysis. Neuroscience. 79: 497-507. PMID 9200732 DOI: 10.1016/S0306-4522(96)00689-6 |
0.595 |
|
| 1995 |
Rivest R, Falardeau P, Paolo TD. Brain dopamine transporter: gender differences and effect of chronic haloperidol. Brain Research. 692: 269-272. PMID 8548314 DOI: 10.1016/0006-8993(95)00611-S |
0.505 |
|
| 1995 |
Allard S, Labbé M, Falardeau P. Recombination of endogenous D2 dopamine receptor gene with a metallothionein promoter in GH4C1 cells confers functional and inducible D2 response. Biochimica Et Biophysica Acta. 1260: 43-8. PMID 7999793 DOI: 10.1016/0167-4781(94)00176-4 |
0.596 |
|
| 1995 |
Wang X, Sato N, Greer MA, Falardeau P. Pituitary Prl Secretion Induced By Tetraethylammonium Is Inhibited By Dopamine Through D2 Receptors Molecular and Cellular Endocrinology. 112: 153-157. PMID 7489818 DOI: 10.1016/0303-7207(95)03580-Z |
0.554 |
|
| 1988 |
Paolo TD, Falardeau P, Morissette M. Striatal D-2 dopamine agonist binding sites fluctuate during the rat estrous cycle Life Sciences. 43: 665-672. PMID 3412110 DOI: 10.1016/0024-3205(88)90137-3 |
0.561 |
|
| 1988 |
Falardeau P, Bouchard S, Bédard PJ, Boucher R, Di Paolo T. Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys. European Journal of Pharmacology. 150: 59-66. PMID 3261249 DOI: 10.1016/0014-2999(88)90750-9 |
0.554 |
|
| 1988 |
Rouillard C, Bédard P, Falardeau P, Di Paolo T. Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion. European Journal of Pharmacology. 157: 125-33. PMID 2975996 DOI: 10.1016/0014-2999(88)90375-5 |
0.575 |
|
| 1988 |
Falardeau P, Bédard PJ, Paolo TD. Relation between brain dopamine loss and D2 dopamine receptor density in MPTP monkeys. Neuroscience Letters. 86: 225-229. PMID 2966905 DOI: 10.1016/0304-3940(88)90575-7 |
0.542 |
|
| 1987 |
Kuchel O, Racz K, Debinski W, Falardeau P, Buu NT. Contrasting dopaminergic patterns in two forms of genetic hypertension. Clinical and Experimental Hypertension. Part a, Theory and Practice. 9: 987-1008. PMID 3621631 DOI: 10.3109/10641968709161461 |
0.344 |
|
| 1987 |
Paolo TD, Falardeau P. Guanine nucleotide regulation of dopamine receptor agonist affinity states in rat estradiol-induced pituitary tumors Life Sciences. 41: 1149-1153. PMID 3613869 DOI: 10.1016/0024-3205(87)90634-5 |
0.509 |
|
| 1987 |
Rouillard C, Bédard PJ, Falardeau P, Dipaolo T. Behavioral and biochemical evidence for a different effect of repeated administration of l-DOPA and bromocriptine on denervated versus non-denervated striatal dopamine receptors Neuropharmacology. 26: 1601-1606. PMID 3431663 DOI: 10.1016/0028-3908(87)90008-6 |
0.53 |
|
| 1987 |
Falardeau P, Paolo TD. Regional effect of estradiol on rat caudate-putamen dopamine receptors: lateral-medial differences. Neuroscience Letters. 74: 43-48. PMID 2951620 DOI: 10.1016/0304-3940(87)90048-6 |
0.624 |
|
| 1986 |
Bédard PJ, Paolo TD, Falardeau P, Boucher R. Chronic treatment with l-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone binding Brain Research. 379: 294-299. PMID 3488796 DOI: 10.1016/0006-8993(86)90783-3 |
0.496 |
|
| 1986 |
Paolo TD, Falardeau P. Regional effect of estradiol on rat caudate-putamen dopamine receptors: Lateral-medial differences Journal of Steroid Biochemistry. 25: 82. DOI: 10.1016/0022-4731(86)90679-5 |
0.55 |
|
| 1985 |
Paolo Td, Falardeau P. Modulation of brain and pituitary dopamine receptors by estrogens and prolactin Progress in Neuropsychopharmacology and Biological Psychiatry. 9: 473-480. PMID 4089182 DOI: 10.1016/0278-5846(85)90004-1 |
0.559 |
|
| 1985 |
George SR, Watanabe M, Di Paolo T, Falardeau P, Labrie F, Seeman P. The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form. Endocrinology. 117: 690-7. PMID 4017954 DOI: 10.1210/Endo-117-2-690 |
0.508 |
|
| 1984 |
Deshaies P, Bedard P, Falardeau P, Paolo TD. Behavioral and biochemical evidence of apomorphine-induced supersensitivity of the striatal dopamine receptors. Neuropharmacology. 23: 1219-1222. PMID 6521857 DOI: 10.1016/0028-3908(84)90243-0 |
0.46 |
|
| 1984 |
Paolo TD, Falardeau P. Dopamine receptors in rat pituitary and estradiol-induced pituitary tumor: Effect of chronic treatment with bromocriptine Biochemical and Biophysical Research Communications. 123: 312-316. PMID 6477585 DOI: 10.1016/0006-291X(84)90414-5 |
0.501 |
|
| 1984 |
Paolo TD, Falardeau P. Effects of a luteinizing hormone-releasing hormone analog on the growth of estrogen-induced prolactin-secreting rat pituitary tumors and its influence on their dopamine receptors European Journal of Pharmacology. 102: 383-384. PMID 6383844 DOI: 10.1016/0014-2999(84)90277-2 |
0.452 |
|
| Show low-probability matches. |